ADRO - Aduro BioTech, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
88.57M
Enterprise Value 3
-109.4M
Trailing P/E
N/A
Forward P/E 1
-1.36
PEG Ratio (5 yr expected) 1
-0.13
Price/Sales (ttm)
5.41
Price/Book (mrq)
1.08
Enterprise Value/Revenue 3
-6.68
Enterprise Value/EBITDA 6
1.33

Trading Information

Stock Price History

Beta (3Y Monthly) 1.45
52-Week Change 3-62.58%
S&P500 52-Week Change 315.09%
52 Week High 34.5900
52 Week Low 30.9010
50-Day Moving Average 31.0421
200-Day Moving Average 31.6654

Share Statistics

Avg Vol (3 month) 3589.79k
Avg Vol (10 day) 31M
Shares Outstanding 580.51M
Float 54.71M
% Held by Insiders 143.11%
% Held by Institutions 142.79%
Shares Short (Oct 31, 2019) 41.7M
Short Ratio (Oct 31, 2019) 42.29
Short % of Float (Oct 31, 2019) 42.62%
Short % of Shares Outstanding (Oct 31, 2019) 42.11%
Shares Short (prior month Sep 30, 2019) 41.51M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-533.39%

Management Effectiveness

Return on Assets (ttm)-16.01%
Return on Equity (ttm)-74.48%

Income Statement

Revenue (ttm)16.38M
Revenue Per Share (ttm)0.20
Quarterly Revenue Growth (yoy)56.70%
Gross Profit (ttm)-60.75M
EBITDA -82.47M
Net Income Avi to Common (ttm)-89.28M
Diluted EPS (ttm)-1.1190
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)231.79M
Total Cash Per Share (mrq)2.88
Total Debt (mrq)33.82M
Total Debt/Equity (mrq)41.22
Current Ratio (mrq)7.26
Book Value Per Share (mrq)1.02

Cash Flow Statement

Operating Cash Flow (ttm)-44.53M
Levered Free Cash Flow (ttm)-19.29M